AU Patent

AU4386901A — Device and methods for the stimulation of body cells through electromagentic radiation

Assigned to MDE MEDIZINTECHNIK GmbH · Expires 2001-09-06 · 25y expired

What this patent protects

Patent listed against aminolevulinic-acid-hydrochloride.

Drugs covered by this patent

aminolevulinic-acid-hydrochloride (AMINOLEVULINIC ACID HYDROCHLORIDE)

Patent Metadata

Patent number: AU4386901A
Jurisdiction: AU
Classification: —
Expires: 2001-09-06
Drug substance claim: No
Drug product claim: No
Assignee: MDE MEDIZINTECHNIK GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.